October 20, 2026

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook Highlights a 28.53% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology industry, is capturing investor attention with its promising financial metrics and a potential upside..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Biotech Player with 181.72% Potential Upside

Ascentage Pharma Group International (AAPG), a Chinese biotechnology firm, is capturing attention with its impressive potential upside of 181.72%, according to recent analyst ratings. With a..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Closer Look at the Biotech’s Revenue Surge Amidst Phase 3 Trials

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands at the forefront of pioneering treatments for rare endocrine diseases and related tumors. With a market capitalization of $9.01 billion,..

PGIM Securitized Income ETF (PINC): Stability Amid Uncertainty with Market Cap Insights

In an unpredictable market landscape, the PGIM Securitized Income ETF (NYSE Arca: PINC) emerges as a noteworthy option for investors in search of stability. With a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Unlocking a 22.69% Potential Upside in Biotechnology

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a standout in the biotechnology sector, has been capturing the attention of investors with its strategic focus on dermatological treatments. Based..

Kymera Therapeutics (KYMR) Stock Analysis: Biotech Innovator with a 28.94% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has emerged as a significant player in the rapidly evolving biotechnology sector, offering a promising outlook for investors keen on innovative..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 59% Potential Upside Amid Robust Revenue Growth

PTC Therapeutics, Inc. (NASDAQ: PTCT), a biopharmaceutical company focused on treating rare disorders, has garnered significant attention due to its impressive revenue growth and potential stock..

CONMED Corporation (CNMD) Stock Analysis: Navigating the Medical Device Sector with Strategic Insights

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector, is making strides in the medical devices industry. Based in Largo, Florida, the company specializes..

Clover Health Investments (CLOV) Stock Analysis: Is a 21% Upside on the Horizon?

Clover Health Investments, Corp (NASDAQ: CLOV) has been making waves in the healthcare sector with its innovative approach to Medicare Advantage plans. As an emerging player,..

Perrigo Company plc (PRGO) Stock Analysis: High Dividend Yield Amidst Challenging Financial Metrics

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, is a significant player in the specialty and generic drug manufacturing industry. Headquartered in Dublin,..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: 277% Potential Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline of drug candidates aimed at addressing..

Tarsus Pharmaceuticals Inc. (TARS) Stock Analysis: Eyeing a 43.6% Potential Upside Amid Robust Revenue Growth

Tarsus Pharmaceuticals, Inc. (TARS), a burgeoning player in the biotechnology sector, has caught the attention of investors with its impressive potential upside and innovative approach to..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech with 192.70% Potential Upside

Investors with an eye on the biotechnology space might want to take a closer look at MoonLake Immunotherapeutics (MLTX), a clinical-stage Swiss company making waves with..

LeMaitre Vascular, Inc. (LMAT): A 30% Upside Potential Ignites Investor Interest

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a stalwart in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its compelling growth potential..

Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: Exploring a 23.3% Potential Upside with Robust Revenue Growth

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 23.3%. This biopharmaceutical..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unpacking a Potential 16.43% Upside in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS), a leading provider of personal care services across the United States, offers a compelling investment opportunity in the healthcare sector. With..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Promising 75% Upside in the Biotechnology Sector

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing the attention of investors within the healthcare sector, thanks to its innovative approach in the biotechnology industry and..

HUTCHMED (China) Limited (HCM): Investor Outlook with 45% Potential Upside

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is drawing attention with a significant potential upside of 45.21% based on its current..

Enovis Corporation (ENOV): Unpacking the 81.60% Potential Upside and Analyst Consensus

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with its substantial 81.60% potential upside. This..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: High Revenue Growth and Strong Buy Ratings Signal Promising Upside

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is making waves in the biotechnology sector, with its innovative therapies for a range of complex conditions. With a market capitalization..

Search

Funds

October 20, 2026

Search

Funds

October 20, 2026

FTSE 100

Funds